BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38263134)

  • 1. MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study.
    Liu Y; Wang Y; Wang X; Xue L; Zhang H; Ma Z; Deng H; Yang Z; Sun X; Men Y; Ye F; Men K; Qin J; Bi N; Wang Q; Hui Z
    Cancer Imaging; 2024 Jan; 24(1):16. PubMed ID: 38263134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning approach using
    Qi WX; Li S; Xiao J; Li H; Chen J; Zhao S
    Front Immunol; 2024; 15():1351750. PubMed ID: 38352868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI and
    Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
    Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using clinical and radiomic feature-based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation.
    Wang J; Zhu X; Zeng J; Liu C; Shen W; Sun X; Lin Q; Fang J; Chen Q; Ji Y
    Eur Radiol; 2023 Dec; 33(12):8554-8563. PubMed ID: 37439939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
    Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
    Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study.
    Li K; Zhang S; Hu Y; Cai A; Ao Y; Gong J; Liang M; Yang S; Chen X; Li M; Tian J; Shan H
    Ann Surg Oncol; 2023 Dec; 30(13):8231-8243. PubMed ID: 37755566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 10. CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study.
    Zhang M; Lu Y; Sun H; Hou C; Zhou Z; Liu X; Zhou Q; Li Z; Yin Y
    Transl Oncol; 2024 Jan; 39():101804. PubMed ID: 37839176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using
    Murakami Y; Kawahara D; Tani S; Kubo K; Katsuta T; Imano N; Takeuchi Y; Nishibuchi I; Saito A; Nagata Y
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34200332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random.
    Qian D; Chen X; Shang X; Wang Y; Tang P; Han D; Jiang H; Chen C; Zhao G; Zhou D; Cao F; Er P; Zhang W; Li X; Zhang T; Zhang B; Guan Y; Wang J; Yuan Z; Yu Z; Wang P; Pang Q
    Radiother Oncol; 2022 Sep; 174():1-7. PubMed ID: 35764191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Liu G; Chen T; Zhang X; Hu B; Yu J
    Cancer Med; 2024 Mar; 13(5):e7075. PubMed ID: 38477511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
    Cai C; Hu T; Rong Z; Gong J; Tong T
    Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
    Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J
    JAMA Surg; 2021 Aug; 156(8):721-729. PubMed ID: 34160577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R
    J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.